APO-Solifenacin solifenacin succinate 5 mg film coated tablets bottle

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

solifenacin succinate, Quantity: 5 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Solifenacin succinate

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: polyvinyl alcohol; lactose; magnesium stearate; iron oxide yellow; hyprolose; macrogol 8000; titanium dioxide; croscarmellose sodium; purified talc

Verabreichungsweg:

Oral

Einheiten im Paket:

30

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Produktbesonderheiten:

Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2016-01-12